se of a substance to prevent and control mouth inflammation caused by radiotherapy
Phase 1
- Conditions
- StomatitisC07.465.864
- Registration Number
- RBR-9yrnbg
- Lead Sponsor
- niversidade Estadual da Paraíba
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Data analysis completed
- Sex
- Not specified
- Target Recruitment
- Not specified
Inclusion Criteria
Patients of both sexes; regardless of ethnicity; over 18 years of age; undergoing head and neck radiotherapy with at least half of the oral mucosa area included in the radiation fields.
Exclusion Criteria
Patients submitted to palliative RT; those who could not open their mouths; and those who used prophylactic topical drugs or mouth rinse; and those who presented Karnofsky Performance Status<70 were excluded; Interruption of use for just one day and not coming to the dental evaluation resulted in the elimination of the patient from the study.
Study & Design
- Study Type
- Intervention
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method